Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7799909

Changes in notifiable diseases data presentation.

Centers for Disease Control and Prevention (CDC)
View original source ↗Export metadata ↓

Abstract

The next issue of MMWR (dated January 13, 1995 [volume 44, number 1]), will incorporate modifications to Tables I and II, Cases of Notifiable Diseases, United States. The purposes of these modifications are to improve the usefulness of notifiable diseases data (1,2) and to respond to changing priorities in notifiable disease surveillance. This report describes the rationale for data dissemination in Table I and Table II.

Explore related subjects

Centers for Disease Control and Prevention, U.S.Disease NotificationHumansUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Centers for Disease Control and Prevention (CDC). 1995-01-06. Changes in notifiable diseases data presentation.. https://pubmed.ncbi.nlm.nih.gov/7799909/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Smallpox vaccination and the patient with an organ transplant.

Organ transplant recipients are vulnerable to a variety of infections because of the immunosuppressed state required to prevent organ rejection. We review the recommendations of the Centers for Disease Control and Prevention (Atlanta, Georgia) for smallpox vaccination and the possible complications of vaccination in the population with organ transplants. The risk of these complications is presumably dependent on the extent of deficient cell-mediated immunity.

Centers for Disease Control and Prevention, U.S.↗
PubMed2003

New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women.

We review two new HIV counseling and testing guidelines by the U.S. Centers for Disease Control and Prevention. The guidelines, which address the general population and pregnant women, reflect an important shift in the goals and methods of counseling and testing that has widespread implications. The guidelines' defining characteristic is the greater emphasis on increasing the numbers of people knowing their HIV status while maintaining the historical focus on extensive pretest counseling and consent procedures. We discuss the policy and practice implications by evaluating five factors: 1) Will the guidelines be adopted? 2) Will at-risk and infected individuals be identified for counseling and testing? 3) Will health care providers offer counseling and testing and patients accept counseling and testing, obtain their test results, seek treatment, and change risky behaviors? 4) Will the guidelines be relatively cost-effective? 5) Will the guidelines be compatible with ethical standards?

Centers for Disease Control and Prevention, U.S.↗